Breaking News

Quanticate Expands Global Biostatistics, Programming Ops

By Kristin Brooks | March 5, 2014

Wins FSP contracts with two large pharma firms

Quanticate is expanding its global resources to support clinical trials in Bangalore and NC in the areas of biostatistics and statistical programming, following the award of functional service provision (FSP) contracts with two large pharma companies.
Quanticate will grow its resource capabilities and will be recruiting staff for a range of roles in biostatistics and statistical programming across all levels throughout 2014, based on its pipeline of work. Opportunities will include graduate to principal roles in India and the U.S. as well as other global locations.
"The expansion of our current customers coupled with the addition of new partnerships and two large-scale FSPs, has resulted in the need to expand our resource base across all our locations," said Daniel Chapple, chief commercial officer. "This expansion will also enable us to extend our presence to other cities in India and we are currently in the process of identifying facilities."
"Many companies are seeing the benefits from companies that can offer global expertise in their niche fields rather than using full service CROs whose primary focus is monitoring and project management," said David Underwood, chief executive officer of Quanticate. Underwood continues, "This approach can also drastically reduce operational oversight on the client side where successful partnerships are built on quality, performance, trust and understanding. It also means clients gain from the big benefit of having subject experts supporting their programs of work."

Related Compliance:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • Choosing Oral Formulations for First-in-man Clinical Trials

    Choosing Oral Formulations for First-in-man Clinical Trials

    Jon Sutch, Senior Manager of Formulation Development, Patheon||October 11, 2016
    Early formulations should be simple, but selecting a simple formulation isn’t as easy as it seems

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research